MedPath

Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction

Phase 4
Recruiting
Conditions
Free Flap Reconstruction
Interventions
Registration Number
NCT06784999
Lead Sponsor
Indiana University
Brief Summary

The main purpose of this study is to determine which type of medication, sufentanil or methadone, is better at controlling pain during and, more importantly, after surgery in patients undergoing a head and neck dissection with free flap or rotational tissue reconstruction. Prior to their operation, subjects will be randomized to receive either Sufentanil or Methadone. After surgery, research staff will obtain information about recovery and pain levels.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
128
Inclusion Criteria
  • • Patients undergoing head and neck dissection with free flap or rotational reconstruction at Indiana University Health Adult Academic Health Center

    • ASA class 1, 2, or 3 (See Appendix)
    • Age 18 to 80
    • male or female
    • Able and willing to provide written informed consent
Exclusion Criteria
  • Any contraindication to opiates, (i.e. allergy to opioids, substance use disorder) as determined by PI review and any contraindications reported by the patient
  • Patient on home methadone at any dose
  • Any physical, mental or medical conditions which, in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery
  • Known true allergy to the study medications (sufentanil, methadone)
  • Any history of substance abuse in the past 6 months which would include heroin or any other illegal street drugs
  • End stage liver disease, end stage renal disease
  • Patient staying intubated or on mechanical ventilation after surgery
  • Patient (home dose) taking more than 30mg PO morphine equivalent (OME) per day
  • Any additional and concurrent surgical procedures to the patient

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sufentanilsufentanil1. Intravenous sufentanil starting at a dose of 0.5 mcg/kg/min hr ideal body weight (IBW) at the beginning of the case, prior to surgical incision, with a discontinuation of the infusion when the surgical microscope is removed from the patient field and the closure of the incision(s) begins. (n=64)
Methadonemethadone2. Intravenous methadone of 0.2 mg/kg IBW up to a maximum dose of 20mg, rounded to the nearest milligram. The methadone will be given at the beginning of the case, prior to surgical incision. n=64)
Primary Outcome Measures
NameTimeMethod
IV morphine equivalent24 hours

Cumulative milligrams IV morphine equivalent

Secondary Outcome Measures
NameTimeMethod
Opioid side effect - NauseaAfter arrival time to post anesthesia care unit until 24 hrs./completion of study

Incident of opioid side effect - Nausea

Pain Scores24 hour after arrival time in post anesthesia care unit

Visual analog scale (VAS) pain score on a scale of 1-10 (increments of 1 unit), 1 being no pain at all and 10 being the most pain the patient has ever experienced

Opioid Consumption24 hour after arrival time in post anesthesia care unit

Opioid Consumption and morphine equivalent (MME)

Opioid side effect - PuritisAfter arrival time to post anesthesia care unit until 24 hrs./completion of study

Incident of opioid side effect - Puritis

Opioid side effect - Respiratory DepressionAfter arrival time to post anesthesia care unit until 24 hrs./completion of study

Incident of opioid side effect - Respiratory Depression

Trial Locations

Locations (1)

Indiana University

🇺🇸

Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath